The relationship between exercise and mitochondrial function is one of the most intensively studied areas in physiology. Exercise is widely recognized as a potent driver of mitochondrial biogenesis — the process by which cells increase their mitochondrial content in response to metabolic demand. MOTS-c, a 16-amino acid peptide encoded by mitochondrial DNA, sits at a mechanistically interesting intersection: it is both influenced by exercise and appears to participate in the molecular signaling that links exercise to metabolic adaptation.
This article reviews what published research has established about the relationship between MOTS-c and exercise, focusing on circulating levels, signaling pathways, and the current state of the science. All content is for educational purposes only.
What Is MOTS-c?
MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a short open reading frame encoded within the 12S ribosomal RNA gene of human mitochondrial DNA. The peptide was characterized in 2015 by Lee et al. in a landmark Cell Metabolism paper that identified it as a mitochondrially encoded hormone capable of promoting metabolic homeostasis and reducing obesity and insulin resistance in preclinical models (PMID: 25738459).
Unlike most peptide hormones, which are encoded by nuclear DNA and produced in specialized secretory cells, MOTS-c is produced within the mitochondria themselves — organelles present in virtually every cell of the body. This means MOTS-c can potentially be produced locally in response to the metabolic demands of any mitochondria-rich tissue, including skeletal muscle, which is both the primary engine of exercise metabolism and among the most metabolically active tissues in the body.
Exercise Elevates Circulating MOTS-c in Humans
The most direct evidence connecting MOTS-c to exercise comes from studies measuring circulating peptide levels before and after physical activity. Von Walden et al. (2021) published a study in the Journal of Applied Physiology examining whether acute endurance exercise stimulates circulating levels of mitochondria-derived peptides, including MOTS-c, in human subjects (PMID: 34351816). The study found that circulating levels of MOTS-c were elevated following an acute endurance exercise bout, consistent with the hypothesis that exercise activates mitochondrial signaling through MDP secretion.
This finding is significant because it places MOTS-c alongside other exercise-responsive signaling molecules — including irisin, IL-6, and brain-derived neurotrophic factor (BDNF) — as a potential exercise-induced circulating factor. It also raises questions about whether some of the systemic benefits of exercise, such as improved insulin sensitivity and metabolic flexibility, may be partially mediated through MOTS-c signaling.
MOTS-c and AMPK: The Exercise-Metabolism Link
One of the central mechanisms by which MOTS-c appears to exert metabolic effects is through activation of AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor that is activated when the ratio of AMP to ATP rises — exactly the condition that occurs in exercising muscle when energy demand outpaces immediate ATP supply. AMPK activation triggers a suite of adaptive responses: increased glucose uptake via GLUT4 translocation, enhanced fatty acid oxidation, reduced protein synthesis, and initiation of mitochondrial biogenesis through PGC-1alpha.
Lee et al. (2016) described MOTS-c’s regulation of muscle and fat metabolism in the context of AMPK activation, noting that the peptide’s effects on glucose homeostasis involved this pathway (PMID: 27216708). The mechanistic overlap between MOTS-c signaling and AMPK activation suggests that MOTS-c may function as part of the cellular machinery that couples mitochondrial metabolic sensing to downstream adaptations.
Yang et al. (2021) investigated this further in a mouse study examining the interaction between MOTS-c and exercise. They reported that MOTS-c interacted synergistically with exercise to regulate PGC-1alpha expression, attenuate insulin resistance, and enhance glucose metabolism via the AMPK signaling pathway (PMID: 33722744). The synergistic effect is notable: it suggests that the combination of MOTS-c and exercise produces metabolic outcomes greater than either condition alone, at least in the mouse model studied.
PGC-1alpha: A Shared Target of Exercise and MOTS-c
PGC-1alpha (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is a transcriptional coactivator widely considered the master regulator of mitochondrial biogenesis. Exercise robustly increases PGC-1alpha expression in skeletal muscle, and this upregulation drives the production of new mitochondria, improved oxidative capacity, and enhanced metabolic flexibility — adaptations that define the trained muscle phenotype.
The finding that MOTS-c administration in Yang et al. (2021) also elevated PGC-1alpha expression, and that this effect was amplified in exercising animals, places MOTS-c within the same regulatory circuit as exercise-induced mitochondrial adaptation. Whether MOTS-c acts upstream of PGC-1alpha as an activator, or whether both are downstream consequences of shared AMPK activation, is an area where further mechanistic research is needed.
Skeletal Muscle as a Site of MOTS-c Production and Action
Skeletal muscle is both a major producer and target of MOTS-c. Given that skeletal muscle contains a high density of mitochondria and undergoes the greatest metabolic flux during exercise, it is a logical site for MOTS-c biology. Research by Lee et al. (2016) specifically highlighted MOTS-c’s effects on muscle metabolism, including its capacity to regulate fatty acid utilization and glucose uptake in muscle cells (PMID: 27216708).
Kumagai et al. (2022) added a genetic dimension to MOTS-c muscle biology by reporting that the MOTS-c K14Q polymorphism in mtDNA is associated with muscle fiber composition and muscular performance in human subjects (PMID: 34728329). This finding suggests that genetic variation in MOTS-c itself influences muscle phenotype, providing a potential pathway through which mitochondrial genetic variation affects exercise capacity and metabolic health.
MOTS-c, Insulin Sensitivity, and Exercise: An Integrated View
The metabolic effects of MOTS-c and exercise converge on several shared endpoints. Improved insulin sensitivity is the most consistently documented benefit of regular aerobic exercise, and it is also among the primary effects attributed to MOTS-c in preclinical models. Both appear to involve AMPK activation, GLUT4 expression and translocation, and PGC-1alpha-mediated mitochondrial adaptation.
This raises an interesting research question: is MOTS-c one of the molecular mechanisms through which exercise improves insulin sensitivity? The data from Von Walden et al. (2021) showing that exercise increases circulating MOTS-c, and the Yang et al. (2021) data showing synergistic effects of MOTS-c plus exercise on insulin resistance, are consistent with this hypothesis but do not establish it definitively. Controlled intervention studies in humans that track MOTS-c levels alongside insulin sensitivity markers across exercise programs would be needed to test this hypothesis more rigorously.
Age, Exercise Capacity, and MOTS-c Decline
Circulating MOTS-c levels appear to decline with age, a pattern consistent with broader evidence for mitochondrial dysfunction as a contributor to aging. Age-related declines in exercise capacity and metabolic health overlap substantially with the proposed biological activities of MOTS-c. This convergence has generated interest in MOTS-c as a potential research model for understanding the mitochondrial basis of age-related metabolic decline and the mechanisms through which exercise may slow that decline.
The Lee et al. (2015) paper noted that MOTS-c administration to aging mice produced metabolic benefits, and that the peptide appeared to act as a regulator that coordinates cellular metabolism with the organism’s overall energy status — a role that could become increasingly important as mitochondrial signaling capacity diminishes with age.
Current Research Limitations
The MOTS-c and exercise research field is relatively young, and several important limitations apply to the current body of evidence:
- Most mechanistic studies have been conducted in rodent models. Human data on MOTS-c’s effects on exercise metabolism are largely observational (measuring circulating levels), with limited controlled intervention data.
- The optimal exercise modalities, intensities, and durations for MOTS-c elevation have not been systematically characterized.
- Whether exogenously administered MOTS-c in research models produces effects similar to endogenous, exercise-stimulated MOTS-c is not fully established.
- Assay standardization for circulating MOTS-c measurement is still evolving, which may affect comparability across studies.
These limitations underscore the need for caution when extrapolating from current preclinical and mechanistic data to conclusions about human physiology.
Researchers exploring MOTS-c in the context of exercise and metabolism can find the MOTS-c peptide research guide on CertaPeptides for foundational background, and the MOTS-c vs Humanin comparison article for context within the broader mitochondria-derived peptide family. MOTS-c for laboratory research is available at the CertaPeptides MOTS-c product page.
Key Takeaways
- Acute endurance exercise elevates circulating MOTS-c levels in humans, as documented by von Walden et al. (2021), positioning MOTS-c as an exercise-responsive mitochondria-derived peptide.
- MOTS-c activates AMPK, a central mediator of exercise-induced metabolic adaptation, creating mechanistic overlap between MOTS-c signaling and exercise biology.
- In mouse models, MOTS-c and exercise interact synergistically to regulate PGC-1alpha expression and improve insulin resistance (Yang et al., 2021).
- Genetic variation in MOTS-c (K14Q polymorphism) is associated with differences in muscle fiber composition and performance, linking MOTS-c biology to exercise capacity.
- The field is early-stage in humans — controlled exercise intervention studies tracking MOTS-c alongside metabolic outcomes are needed to establish causal relationships.
Frequently Asked Questions
Does exercise increase MOTS-c levels?
Yes. Research by von Walden et al. (2021) demonstrated that acute endurance exercise stimulates circulating levels of MOTS-c in human subjects. The extent to which different exercise types, intensities, or durations influence MOTS-c levels has not been systematically mapped.
How does MOTS-c relate to insulin sensitivity?
Preclinical research indicates that MOTS-c administration improves insulin sensitivity in mouse models of obesity and metabolic disease. The mechanism involves AMPK activation and downstream effects on glucose uptake and fat metabolism. Whether and to what degree these effects translate to humans is an area of ongoing investigation.
What is AMPK and why does it matter for exercise?
AMPK (AMP-activated protein kinase) is a cellular energy sensor that activates when ATP is depleted, as occurs during exercise. It triggers adaptive responses including increased glucose uptake, enhanced fat oxidation, and initiation of mitochondrial biogenesis. MOTS-c’s activation of AMPK overlaps mechanistically with how exercise drives these same adaptations.
Is MOTS-c the same as an exercise mimetic?
Some researchers have categorized MOTS-c as a potential exercise mimetic — a compound that activates pathways overlapping with those stimulated by exercise. The synergistic interaction observed in the Yang et al. (2021) mouse study suggests the relationship may be more complex than simple mimicry. Research in this area is ongoing and not yet definitive for human applications.
What role does PGC-1alpha play in MOTS-c biology?
PGC-1alpha is a key transcriptional coactivator that drives mitochondrial biogenesis and is a major mediator of exercise adaptation. Research suggests that MOTS-c administration elevates PGC-1alpha expression and that this effect is amplified in combination with exercise in mouse models. Whether MOTS-c acts directly upstream of PGC-1alpha or through shared upstream regulators like AMPK remains under investigation.
References
- Lee C, Zeng J, Drew BG, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. PMID: 25738459
- Lee C, Kim KH, Cohen P. (2016). MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. PMID: 27216708
- Yang B, Yu Q, Chang B, et al. (2021). MOTS-c interacts synergistically with exercise intervention to regulate PGC-1alpha expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim Biophys Acta Mol Basis Dis. PMID: 33722744
- von Walden F, Fernandez-Gonzalo R, Norrbom J, et al. (2021). Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans. J Appl Physiol (1985). PMID: 34351816
- Kumagai H, Natsume T, Kim SJ, et al. (2022). The MOTS-c K14Q polymorphism in the mtDNA is associated with muscle fiber composition and muscular performance. Biochim Biophys Acta Gen Subj. PMID: 34728329
Disclaimer: This article is for educational and research purposes only. The information provided does not constitute medical advice. Always consult qualified professionals before beginning any research protocol. CertaPeptides products are sold for laboratory research use only and are not intended for human consumption.